Delivery Order SPE2DX22D0049-SPE2D825FB1EA
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $34,139.94 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, competitively awarded delivery order (Contract No. 4569285368) is being performed at the company's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger indefinite delivery vehicle, this award represents one of numerous...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,818.20 to AmerisourceBergen Drug Corp on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $64,380.48 to AmerisourceBergen Drug Corp on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price, competitively awarded contract (no set-aside designation) represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order contract valued at $5,739.90 to AmerisourceBergen Drug Corp on August 11, 2025, with a completion date of August 12, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $24,831.66 to AmerisourceBergen Drug Corp on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. AmerisourceBergen, headquartered in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $275,118.44 to AmerisourceBergen Drug Corp on August 23, 2025, for pharmaceutical and medical supply delivery. This firm fixed price delivery order, which concludes August 25, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $56,274.48 to AmerisourceBergen Drug Corp on September 13, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order, issued as a competitive award with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is for pharmaceutical products and...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $77,463.67 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, effective through August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The award is non-set-aside and was competitively...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $11,379.98 to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The award is performed at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $14,731.84 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This non-set-aside competitive award (Contract No. 4568975942) represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The contract will be performed at...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D825FB1EADelivery Order
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $14,408.88 to AmerisourceBergen Drug Corp on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply products. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor supplying an extensive portfolio of pharmaceutical products and medical supplies to military and veteran healthcare systems. The company's federal contract awards encompass brand-name and generic medications, vaccines, medical devices, specialty pharmaceuticals, and specialized healthcare commodities across multiple therapeutic domains. Through the DLA Troop Support Medical IDC, AmerisourceBergen maintains the capability to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally, positioning the company as a primary vendor for comprehensive military medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.4k | 9/15/25 |